Exploring predictive biomarkers in the treatment of anti-VEGF-A therapy on wet-AMD

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037578

Enrollment

Unknown

Registered

2020-08-29

Start date

2020-09-30

Completion date

Unknown

Last updated

2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wet age-related macular degeneration

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with wet age-related macular degeneration without any treatment; 2. Patients with polypoidal choroidal vasculopathy without any treatment; 3. Patients with age-related cataract.

Exclusion criteria

Exclusion criteria: 1. Patients with retinal hemangioma proliferation; 2. Cataract patients with other eye diseases.

Design outcomes

Primary

Measure	Time frame
BCVA;Central retinal thickness;Predictive biomarkers of aqueous humor;Predictive biomarkers of blood plasma;Predictive biomarkers of peripheral Blood;	—

Countries

China

Contacts

Public ContactXuri Li

Zhongshan Ophthalmic Center of Sun Yat-sen University

lixr6@mail.sysu.edu.cn+86 20-66619344

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026